NCT04432428View on ClinicalTrials.gov

Safety and Efficacy of Patient Controlled Analgesia Using the Sublingual Sufentanil Tablet System (SSTS) in a Fast Track Rehabilitation Program After Total Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 26, 2020

Primary Completion Date

August 31, 2021

Study Completion Date

September 19, 2021

Conditions
Postoperative Pain
Interventions
DRUG

Sufentanil Sublingual Tablet

"all patients will receive tablets for sublingual use, containing 15 microgram of sufentanil. The sufentanil tablets come in a cartridge (40 tablets) and are administered with a special patient-controlled device that uses thumb tag recognition.~max dose per hour : 3 tablets of 15µg sufentanil"

Trial Locations (1)

9000

University Hospital Ghent, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT04432428 - Safety and Efficacy of Patient Controlled Analgesia Using the Sublingual Sufentanil Tablet System (SSTS) in a Fast Track Rehabilitation Program After Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter